Prostate Cancer Research advocates for screening men at high risk of prostate cancer starting at age 45, driven by financial and health considerations. Current guidelines lack a formal screening program in the UK. Olympic cyclist Sir Chris Hoy’s recent diagnosis has prompted renewed attention to the issue. The debate centers on the effectiveness and risks of screening, with conflicting clinical trial results. Experts highlight the psychological and physical consequences of diagnosing low-risk cancers, suggesting targeted screening for high-risk groups, particularly Black men. A report indicates early detection may outweigh treatment harms fourfold.